2017欧洲神经内分泌肿瘤学会共识解读:胰腺神经内分泌瘤诊治更新要点

摘要

Neuroendocrine tumors(NET) is a rare tumor with high heterogeneity.Pancreatic NET is the most common type in China.European Neuroendocrine Tumor Society(ENETS) has launched the ENETS guidelines since 2006 and published the ENETS standard of care in 2009.With the newly targeted therapies and further research on NET,2017 new edition of the ENETS standard of care has changed a lot in the diagnosis and treatment of NET.This article explains the update of pancreatic NET in the 2017 edition of the ENETS standard of care,and introduces pancreatic NET from pathology,imaging examination,surgery,systemic therapy,etc.,and deepens the understanding of the diagnosis and treatment of pancreatic NET.%神经内分泌瘤(NET)发病率低,异质性高.在中国,胰腺NET是最常见的NET类型.欧洲神经内分泌肿瘤学会(ENETS)自2006年开始推出ENETS指南,在2009年又推出ENETS诊疗规范.随着多种靶向治疗药物的问世和对NET的深入研究,2017年新版ENETS诊疗规范在NET的诊断和治疗方面有了新的变化.本文对2017年版ENETS诊疗规范的胰腺NET更新内容做出解读,分别从病理学、影像学检查、手术、系统治疗等方面介绍胰腺NET,加深对胰腺NET诊断和治疗的新认识.